• Drug: Tyvaso (treprostinil inhalation solution & powder)
  • Manufacturer: United Therapeutics

  • Route of Administration: Inhalation

  • Site of Care: Outpatient
  • Approved Indication:

    • pulmonary arterial hypertension (WHO group 1) to improve exercise ability
    • pulmonary hypertension associated with interstitial lung disease (PH-ILD, WHO group 3) to improve exercise ability
  • Disease: pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease (PH-ILD)

  • Therapeutic Area: Pulmonary

  • Enrollment Form Link: Enrollment Form
  • Phone Number: 1-844-864-8437
  • Fax Number: 1-800-380-5294
  • Product Website: tyvaso.com